T. Bernhardt

Effects of Molidustat in the Treatment of Anemia in CKD.

I. Macdougall, T. Akizawa, J. Berns, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease

I. Macdougall, T. Akizawa, Hiroyasu Yamamoto, 2019, Nephron.

α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients

M. Griese, P. Latzin, D. Hartl, 2006, European Respiratory Journal.

SP309SAFETY AND EFFICACY OF MOLIDUSTAT IN ERYTHROPOIESIS STIMULATING AGENTS (ESA) PRE-TREATED ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)

I. Macdougall, T. Akizawa, Thilo Krüger, 2016 .

SO036MOLIDUSTAT INCREASES HAEMOGLOBIN IN ERYTHROPOIESIS STIMULATING AGENTS (ESA)-NAIVE ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)

I. Macdougall, T. Akizawa, J. Berns, 2016 .

The Potential of Comparative Genomic Hybridization as a Tool in the Differential Diagnosis of Matrix-Producing Bone Lesions

W. Winkelmann, S. Bielack, W. Böcker, 2006, International journal of surgical pathology.

Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies

I. Macdougall, T. Akizawa, K. Iekushi, 2019, American Journal of Nephrology.